IE
ZEAL

Israel Englander’s Zealand Pharma A/S American Depositary Shares ZEAL Stock Holding History

Israel Englander’s Portfolio ZEAL Stock Details ZEAL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-85,799
Closed -$1.42M – 4334
2018
Q3 		$1.42M Sell
85,799
-73,774
-46% -$1.11M ﹤0.01% 2664
2018
Q2 		$2.02M Sell
159,573
-11,271
-7% -$171K ﹤0.01% 2393
2018
Q1 		$2.57M Buy
170,844
+139,092
+438% +$2.16M ﹤0.01% 2176
2017
Q4 		$432K Sell
31,752
-38,213
-55% -$600K ﹤0.01% 3169
2017
Q3 		$1.34M Buy
+69,965
New +$1.32M ﹤0.01% 2369

Other funds holding ZEAL

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $1.24B AUM 2.91% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.31B AUM 20.77% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Israel Englander's ZEAL Position: Q4 2018 in Review

Israel Englander sold out of Zealand Pharma A/S American Depositary Shares (ZEAL) in Q4 2018, closing a stake of 85,799 shares — an estimated $1.42M sold.

Israel Englander first reported a position in ZEAL in Q3 2017 and held it in 5 quarters. The position peaked at $2.57M in Q1 2018. 13 funds tracked by Wall St. Rank hold ZEAL as of Q4 2018.

  • Israel Englander reported no remaining Zealand Pharma A/S American Depositary Shares position as of Q4 2018 after selling out during the quarter.
  • Israel Englander sold 85,799 Zealand Pharma A/S American Depositary Shares shares in Q4 2018, an estimated $1.42M.
  • Israel Englander first reported a position in Zealand Pharma A/S American Depositary Shares in Q3 2017 and held it in 5 quarters.
  • Israel Englander's Zealand Pharma A/S American Depositary Shares position peaked at $2.57M in Q1 2018.
  • 13 funds tracked by Wall St. Rank held Zealand Pharma A/S American Depositary Shares as of Q4 2018.

Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.